Full history for every metric is available with a Kvantra account

Stock profile
Sartorius AG ADR logo

Sartorius AG ADR (SOAGY)

Country: GermanySector: HealthcareIndustry: Medical - Instruments & SuppliesExchange: OTC
P/E TTM
85.3
History
P/E NTM
N/A
Market cap
90.98B
Currency USD
KvantraRankAboutN/ANot enough data to calculate KvantraRank
IValue4
IIQuality4
IIIMomentumN/A
Current price
62.27 USD-5.21%
Close 20 Nov 2026
Interval
Benchmarks

Key financial summary

Financials in EUR
202020212022202320242025TTM2026E
Total revenue€m2,3363,4494,1753,3963,3813,3983,6653,737
Operating profit€m626639
Net profit€m21031967820584149219-
EPS reported€0.430.63
Operating cashflow per share€1.832.17
Capex per share€1.231.16
FCF per share€0.601.02
Free cash flow€m206345
Net debt€m3,7313,742
Book value equity€m2,7062,983
Book value per share€7.848.64
Number of sharesm345.23345.26
DPS (TTM paid)€0.150.15

Financial summary

Financials in EUR
202020212022202320242025TTM2026E
Value
P/E TTMx114.9985.34
P/B LTMx6.3127.80
P/S LTMx5.0222.62
P/FCF LTMx82.98240.49
EV/EBITDA LTMx20.2281.43
EV/Sales LTMx6.1223.98
Earnings Yield LTM%0.87%1.17%
FCF Yield%1.21%0.42%
Quality
ROE%5.50%7.81%
ROIC%4.93%5.27%
Operating margin%18.41%17.81%
Gross margin%46.26%45.43%
FCF/Sales%6.05%9.61%
Growth and momentum
EPS Growth YoY%+79.17%+61.54%
Sales Growth YoY%+0.53%+4.27%
Net Income Growth YoY%+77.13%+29.30%
FCF Growth%-63.69%+1.84%
Operating Profit Growth%+43.11%+14.74%
Dividend and capital structure
Dividend Yield%0.29%0.26%
Dividend Growth%+0.70%+0.70%
Payout Ratio%32.81%23.36%
FCF/Debtx0.050.09
Net Debt/EBITDAx3.643.41
EBIT/Net interestx3.292.88
Net debt/market cap%21.86%4.51%
Net debt/Equityx1.381.25
Gross debt/equityx1.581.33

Price target estimates

Low estimate
High estimate
Price consensus
Last year average price target
Current price62.27 USD
Return Potential

Based on consensus from external analysts. Not Kvantra's opinion.

Ratings

Strong Buy
Buy
Hold
Sell
Strong Sell
Number of covering analysts

Based on consensus from external analysts. Not Kvantra's opinion.

ESG

Metric202420252026
ESG-score
Environmental score
Social score
Governance score
Risk rating

Company overview

Sartorius AG, founded in Göttingen, Germany in 1870, is a global supplier of advanced bioprocess solutions, laboratory products, and associated services. The company's diverse portfolio encompasses several critical areas: For biosensing and detection, it provides biosensors, compliance instruments, system software, label-free detection technologies, and SPR systems. In cell analysis, Sartorius offers live-cell analysis platforms, flow cytometry systems, and specialized cell analysis reagents and consumables. Its media and reagent segment includes a wide array of formulations for antibody and recombinant protein production, viral vaccines, regenerative medicine, and stem cell cultivation, along with downstream buffers, microcarriers, strong acids, bases, alcohols, and detergents. The company manufactures various bioreactor systems, from multi-parallel and benchtop units to single-use, stainless steel, cell culture, and microbial bioreactors, all supported by dedicated software applications. Its extensive filtration product line features membranes, blotting products, filter papers, and glass and quartz microfibre products, alongside a comprehensive range of filtration devices for ultrafiltration, sterile filtration, harvesting, analytical and diagnostic sample preparation, particle analysis, pharmaceutical applications, protein/DNA concentration, venting, clarification, and membrane chromatography. Sartorius also delivers solutions for process filtration, process chromatography, fluid management, and cutting-edge process analytical technology with data analytics. Complementary laboratory equipment includes industrial microbiology systems, water purification units, precision weighing and pipetting/dispensing systems, OEM components, and centrifuges. Beyond its products, Sartorius provides essential services such as bioprocess development and engineering, protein expression system optimization, media and process development, comprehensive testing, instrument support, and validation. These offerings primarily serve the life science research, biopharmaceutical manufacturing, quality control and testing, and applied industrial sectors across the globe.

Trades inUSD

Similar companies

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Sartorius AG ADR (SOAGY)

SOAGY · OTC · Healthcare
62.27 USD-5.21%
Sign up to track this stock
Benchmarks
KvantraRankN/A
Market cap90.98B
P/E NTMN/A
P/E TTM85.3
KvantraRank?

Not enough data to calculate KvantraRank

Financialsin EUR
20242025TTM2026E
Analyst target
Consensus
Current62.27 USD
Upside
Price consensus
Last year average price target
Current price62.27 USD
Return Potential

Consensus from external analysts. Not Kvantra's opinion.

Ratings
Strong Buy
Buy
Hold
Sell
Strong Sell

Based on consensus from external analysts. Not Kvantra's opinion.

ESG
202420252026
ESG-score
Environmental score
Social score
Governance score
Risk rating
About

Sartorius AG, founded in Göttingen, Germany in 1870, is a global supplier of advanced bioprocess solutions, laboratory products, and associated services. The company's diverse portfolio encompasses several critical areas: For biosensing and detection, it provides biosensors, compliance instruments, system software, label-free detection technologies, and SPR systems. In cell analysis, Sartorius offers live-cell analysis platforms, flow cytometry systems, and specialized cell analysis reagents and consumables. Its media and reagent segment includes a wide array of formulations for antibody and recombinant protein production, viral vaccines, regenerative medicine, and stem cell cultivation, along with downstream buffers, microcarriers, strong acids, bases, alcohols, and detergents. The company manufactures various bioreactor systems, from multi-parallel and benchtop units to single-use, stainless steel, cell culture, and microbial bioreactors, all supported by dedicated software applications. Its extensive filtration product line features membranes, blotting products, filter papers, and glass and quartz microfibre products, alongside a comprehensive range of filtration devices for ultrafiltration, sterile filtration, harvesting, analytical and diagnostic sample preparation, particle analysis, pharmaceutical applications, protein/DNA concentration, venting, clarification, and membrane chromatography. Sartorius also delivers solutions for process filtration, process chromatography, fluid management, and cutting-edge process analytical technology with data analytics. Complementary laboratory equipment includes industrial microbiology systems, water purification units, precision weighing and pipetting/dispensing systems, OEM components, and centrifuges. Beyond its products, Sartorius provides essential services such as bioprocess development and engineering, protein expression system optimization, media and process development, comprehensive testing, instrument support, and validation. These offerings primarily serve the life science research, biopharmaceutical manufacturing, quality control and testing, and applied industrial sectors across the globe.

IndustryMedical - Instruments & Supplies
CountryGermany
Trades inUSD

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Unlock all fundamental data

Sign up for Free

Unlock all fundamental data

Sign up for Free